2 news items
PROCEPT BioRobotics Announces Real-World, Long-Term Data Demonstrate Sustained Benefits Of Aquablation Therapy For Men With Benign Prostatic Hyperplasia
PRCT
6 May 24
:MP20-01: WATER vs WATER II 5-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30-80 cc and 80-150 cc Prostates
PROCEPT BioRobotics Corp. Announces Investor Event at 2024 AUA Annual Meeting in San Antonio, Texas
PRCT
4 Apr 24
: Reza Zadno – President & Chief Executive OfficerKevin Waters – Executive VP & Chief Financial
- Prev
- 1
- Next